Corrigendum: Expression of Human Epidermal Growth Factor Receptor-2 Status and Programmed Cell Death Protein-1 Ligand Is Associated With Prognosis in Gastric Cancer
Main Authors: | Huifang Lv, Junling Zhang, Keran Sun, Caiyun Nie, Beibei Chen, Jianzheng Wang, Weifeng Xu, Saiqi Wang, Yingjun Liu, Xiaobing Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.672599/full |
Similar Items
-
Expression of Human Epidermal Growth Factor Receptor-2 Status and Programmed Cell Death Protein-1 Ligand Is Associated With Prognosis in Gastric Cancer
by: Huifang Lv, et al.
Published: (2021-02-01) -
Clinical Study of Sintilimab as Second-Line or Above Therapy in Patients With Advanced or Metastatic Gastric Cancer: A Retrospective Study
by: Caiyun Nie, et al.
Published: (2021-09-01) -
Gastric adenocarcinoma expressing human epidermal growth factor receptor in South Asian population
by: Asma Shabbir, et al.
Published: (2018-01-01) -
A PD-1 Inhibitor Induces Complete Response of Advanced Bladder Urothelial Carcinoma: A Case Report
by: Jianzheng Wang, et al.
Published: (2021-06-01) -
PD-L1 and immune infiltrates are differentially expressed in distinct subgroups of gastric cancer
by: H. K. Angell, et al.
Published: (2019-02-01)